FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Oct 18, 2018
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on October 18, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Kathryn A. Krentz (Company Rep)
- Leeterry Moore (Issuing Officer)
View Company Profile
ID · 50f2f7ed-a3fb-498e-a0af-1f0360d52951
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1071044
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 6, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 5, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 24, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 988681 - 2016-10-06
- FDA Inspection 865425 - 2014-02-05
- FDA Inspection 785185 - 2012-04-24
- FDA Inspection 669894 - 2010-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.